Effects of MDMA and Intranasal Oxytocin on Social and Emotional Processing

MDMA (±3,4-methylenedioxymethamphetamine, ‘ecstasy’) is used recreationally, reportedly because it increases feelings of empathy, sociability, and interpersonal closeness. One line of evidence suggests that MDMA produces these effects by releasing oxytocin, a peptide involved in social bonding. In the current study, we investigated the acute effects of MDMA and oxytocin on social and emotional processing in healthy human volunteers. MDMA users (N=65) participated in a 4-session, within-between-subjects study in which they received oral MDMA (0.75, 1.5 mg/kg), intranasal oxytocin (20 or 40 IU), or placebo under double-blind conditions. The primary outcomes included measures of emotion recognition and sociability (desire to be with others). Cardiovascular and subjective effects were also assessed. As expected, MDMA dose-dependently increased heart rate and blood pressure and feelings of euphoria (eg, ‘High’ and ‘Like Drug’). On measures of social function, MDMA impaired recognition of angry and fearful facial expressions, and the larger dose (1.5 mg/kg) increased desire to be with others, compared with placebo. Oxytocin produced small but significant increases in feelings of sociability and enhanced recognition of sad facial expressions. Additionally, responses to oxytocin were related to responses to MDMA with subjects on two subjective measures of sociability. Thus, MDMA increased euphoria and feelings of sociability, perhaps by reducing sensitivity to subtle signs of negative emotions in others. The present findings provide only limited support for the idea that oxytocin produces the prosocial effects of MDMA.

[1]  Gregory M. Miller,et al.  MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment , 2006, Psychopharmacology.

[2]  Jan Born,et al.  Sniffing neuropeptides: a transnasal approach to the human brain , 2002, Nature Neuroscience.

[3]  Harriet de Wit,et al.  Is Ecstasy an “Empathogen”? Effects of ±3,4-Methylenedioxymethamphetamine on Prosocial Feelings and Identification of Emotional States in Others , 2010, Biological Psychiatry.

[4]  R. Tallarida,et al.  Manual of Pharmacologic Calculations , 1981 .

[5]  K. Macdonald,et al.  Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders , 2013, Front. Neurosci..

[6]  K. Rice,et al.  Amphetamine‐type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin , 2001, Synapse.

[7]  Suah Kim,et al.  Oxytocin can hinder trust and cooperation in borderline personality disorder. , 2011, Social cognitive and affective neuroscience.

[8]  S. Herpertz,et al.  Oxytocin Improves “Mind-Reading” in Humans , 2007, Biological Psychiatry.

[9]  N. Bolger,et al.  Social effects of oxytocin in humans: context and person matter , 2011, Trends in Cognitive Sciences.

[10]  H. Wit,et al.  Effect of setting on the reinforcing and subjective effects of ethanol in social drinkers , 1995, Psychopharmacology.

[11]  A. M. Etgen,et al.  Steroid priming promotes oxytocin-induced norepinephrine release in the ventromedial hypothalamus of female rats , 1993, Brain Research.

[12]  J. Parsons,et al.  Prevalence and Predictors of Club Drug Use among Club-Going Young Adults in New York City , 2006, Journal of Urban Health.

[13]  M. Tancer,et al.  Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP. , 2003, Drug and alcohol dependence.

[14]  A. Gratton,et al.  Oxytocin-dopamine interactions mediate variations in maternal behavior in the rat. , 2010, Endocrinology.

[15]  H. de Wit,et al.  In the company of others: social factors alter acute alcohol effects , 2013, Psychopharmacology.

[16]  M. Liechti,et al.  Effects of MDMA alone and after pretreatment with reboxetine, duloxetine, clonidine, carvedilol, and doxazosin on pupillary light reflex , 2012, Psychopharmacology.

[17]  Larry J. Young,et al.  Neuropeptidergic regulation of affiliative behavior and social bonding in animals , 2006, Hormones and Behavior.

[18]  I. McGregor,et al.  Acute Prosocial Effects of Oxytocin and Vasopressin When Given Alone or in Combination with 3,4-Methylenedioxymethamphetamine in Rats: Involvement of the V1A Receptor , 2013, Neuropsychopharmacology.

[19]  Lisa,et al.  assisted psychotherapy : a Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects , 2012 .

[20]  P. Ekman.  Pictures of Facial Affect , 1976 .

[21]  Florence Levy,et al.  A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research , 2011, Psychoneuroendocrinology.

[22]  Andrew H Kemp,et al.  The Impact of a Single Administration of Intranasal Oxytocin on the Recognition of Basic Emotions in Humans: A Meta-Analysis , 2013, Neuropsychopharmacology.

[23]  G. Gimpl,et al.  The oxytocin receptor system: structure, function, and regulation. , 2001, Physiological reviews.

[24]  Jon C. Cole,et al.  The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy , 2006, Journal of psychopharmacology.

[25]  P. Cowen,et al.  Oxytocin enhances processing of positive versus negative emotional information in healthy male volunteers , 2009, Journal of psychopharmacology.

[26]  M. Bakermans-Kranenburg,et al.  Elevated Salivary Levels of Oxytocin Persist More than 7 h after Intranasal Administration , 2012, Front. Neurosci..

[27]  Ulrike Ehlert,et al.  Intranasal Oxytocin Increases Positive Communication and Reduces Cortisol Levels During Couple Conflict , 2009, Biological Psychiatry.

[28]  H. Gu,et al.  Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs , 2006, BMC pharmacology.

[29]  I. McGregor,et al.  A role for oxytocin and 5-HT1A receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine (“ecstasy”) , 2007, Neuroscience.

[30]  Simone G. Shamay-Tsoory,et al.  Intranasal Administration of Oxytocin Increases Envy and Schadenfreude (Gloating) , 2009, Biological Psychiatry.

[31]  H. Wit,et al.  Acute Effects of d-Amphetamine During the Early and Late Follicular Phases of the Menstrual Cycle in Women , 2000, Pharmacology Biochemistry and Behavior.

[32]  U. Fischbacher,et al.  Oxytocin increases trust in humans , 2005, Nature.

[33]  P. Zak,et al.  Oxytocin Increases Generosity in Humans , 2007, PloS one.

[34]  John T. Cacioppo,et al.  Oxytocin increases autonomic cardiac control: Moderation by loneliness , 2011, Biological Psychology.

[35]  I. McGregor,et al.  Breaking the loop: Oxytocin as a potential treatment for drug addiction , 2012, Hormones and Behavior.

[36]  J. Mendelson,et al.  Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans , 2002, Psychopharmacology.

[37]  D. Pine,et al.  Oxytocin improves specific recognition of positive facial expressions , 2010, Psychopharmacology.

[38]  Marilyn A Huestis,et al.  Urinary MDMA, MDA, HMMA, and HMA excretion following controlled MDMA administration to humans. , 2009, Journal of analytical toxicology.

[39]  L. Young,et al.  The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction , 2012, Psychopharmacology.

[40]  H. Wit,et al.  Differential subjective effects of d-amphetamine by gender, hormone levels and menstrual cycle phase , 2002, Pharmacology Biochemistry and Behavior.

[41]  Effects of amphetamine on reactivity to emotional stimuli , 2012, Psychopharmacology.

[42]  C. Kirschbaum,et al.  Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress , 2003, Biological Psychiatry.

[43]  M. Liechti,et al.  MDMA enhances “mind reading” of positive emotions and impairs “mind reading” of negative emotions , 2012, Psychopharmacology.

[44]  Carolyn H. Declerck,et al.  Oxytocin and cooperation under conditions of uncertainty: The modulating role of incentives and social information , 2010, Hormones and Behavior.

[45]  N. Etcoff,et al.  Facial expression megamix: Tests of dimensional and , 1997 .

[46]  B. Jones,et al.  Alcohol consumption increases attractiveness ratings of opposite-sex faces: a possible third route to risky sex. , 2003, Addiction.

[47]  Sabine C. Herpertz,et al.  Effects of intranasal oxytocin on emotional face processing in women , 2010, Psychoneuroendocrinology.

[48]  M. Angstadt,et al.  Effects of MDMA on sociability and neural response to social threat and social reward , 2009, Psychopharmacology.

[49]  M. Kirkpatrick,et al.  Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans. , 2012, Addiction.

[50]  R. Foltin,et al.  Utility of subjective-effects measurements in assessing abuse liability of drugs in humans. , 1991, British journal of addiction.

[51]  A R T Donders,et al.  Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration , 2009, Social neuroscience.

[52]  K. Macdonald,et al.  The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans. , 2010, Harvard review of psychiatry.

[53]  Peter A. Bos,et al.  Acute effects of steroid hormones and neuropeptides on human social–emotional behavior: A review of single administration studies , 2012, Frontiers in Neuroendocrinology.

[54]  Christian Büchel,et al.  Oxytocin Attenuates Amygdala Responses to Emotional Faces Regardless of Valence , 2007, Biological Psychiatry.

[55]  M. Stitzer,et al.  Time allocation in a concurrent schedule of social interaction and monetary reinforcement: Effects of d-amphetamine , 1988, Pharmacology Biochemistry and Behavior.

[56]  F. Graeff,et al.  Anxiolytic-like effect of oxytocin in the simulated public speaking test , 2012, Journal of psychopharmacology.

[57]  Tom Buchanan,et al.  Differential experiences of the psychobiological sequelae of ecstasy use: quantitative and qualitative data from an internet study , 2006, Journal of psychopharmacology.

[58]  Tadashi Kimura,et al.  Evidence That Oxytocin Exerts Anxiolytic Effects via Oxytocin Receptor Expressed in Serotonergic Neurons in Mice , 2009, The Journal of Neuroscience.